Free shipping on all orders over $ 500

PF-3644022 

Cat. No. M28107

All AbMole products are for research use only, cannot be used for human consumption.

PF-3644022  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Quality Control & Documentation
Biological Activity

PF-3644022 is a potent, selective, orally active and ATP-competitive MAPKAPK2 (MK2) inhibitor with an IC50 of 5.2 nM and a Ki of 3 nM. PF-3644022 also inhibits MK3 and p38 regulated/activated kinase (PRAK) with IC50s of 53 nM and 5.0 nM, respectively. PF-3644022 potently inhibits TNFα production and has anti-inflammatory effect.

Chemical Information
Molecular Weight 374.46
Formula C21H18N4OS
CAS Number 1276121-88-0
Form Solid
Solubility (25°C) DMSO 41.67 mg/mL (ultrasonic and warming and heat to 60°C)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Lei Yu, et al. Ann Palliat Med. Role of MK2 signaling pathway mediating microglia/macrophages polarization in chronic compression injury of cervical spinal cord

[2] Kiersten L Berggren, et al. Oncogene. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma

[3] Yizhu Li, et al. Cancer Lett. Inhibition of MAPKAPK2/MK2 facilitates DNA replication upon cancer cell treatment with gemcitabine but not cisplatin

[4] Hongxing Song, et al. Am J Transl Res. Role of MK2 signaling pathway in the chronic compression of cervical spinal cord

[5] Robert J Mourey, et al. J Pharmacol Exp Ther. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation

Related MAPKAPK2/MAP3K/MAP4K Products
(R)-Zunsemetinib

(R)-Zunsemetinib is the isomer of Zunsemetinib, it can be used as an experimental control. Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor.
ASK1-IN-1

ASK1-IN-1 is a novel CNS-penetrant apoptosis signal-regulating kinase 1 (ASK1) inhibitor with good potency (cell IC50 = 138 nM), low clearance (rat Cl/Clu = 0.36/6.7 L h-1 kg-1) and good CNS penetration (rat K p,uu = 0.38).
GNE-8505 

GNE-8505 is an orally available inhibitor of Dual leucine zipper kinase (DLK).
TAK1-IN-3 

TAK1-IN-3 is a potent ATP-competitive TAK1 inhibitor.
MSC 2032964A 

MSC 2032964A is an orally active, selective inhibitor for apoptosis signal-regulating kinase 1(ASK1) with IC50 of 96 nM.
  Catalog
Abmole Inhibitor Catalog




Keywords: PF-3644022  supplier, MAPKAPK2/MAP3K/MAP4K, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.


 
Get to Know Us
Customer Support
Resources
Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.